New York, NY, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Ovarian Cancer Market by Type (Epithelial Ovarian Tumors, Ovarian Germ Cell Tumors, Ovarian Stromal Tumors, and Primary Peritoneal Carcinoma), by Cancer Stage (Stage I, Stage II, Stage III, and Stage IV), by Diagnostics (Physical Examination, Biopsy, Blood Tests, Human Chorionic Gonadotropin (hCG) test, ultrasound, MRI, PET, and CT scans), and by Treatment (Chemotherapy, Targeted Therapy, Radiation Therapy, Immunotherapy, Hormonal Therapy, and Surgery): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 - 2024” . According to the report, global ovarian cancer market was valued at approximately USD 1.83 billion in 2017 and is expected to generate revenue of around USD 4.01 billion by end of 2024, growing at a CAGR of around 11.82% between 2018 and 2024.
Ovaries are located on each side of the uterus and are a part of the female reproductive system. Ovaries produce ovum and female hormones progesterone and estrogen. These female hormones manage the menstrual cycle along with influencing the development of female body characteristics.
Browse through 87 Tables & 21 Figures spread over 110 Pages and in-depth TOC on “Global Ovarian Cancer Market: By Industry Type, Size, Share, Trends and Forecast, 2017 - 2024”.
Request Free Sample Report of Global Ovarian Cancer Market Report @ https://www.zionmarketresearch.com/sample/ova...cer-market
There are four major types of ovarian cancer: Epithelial ovarian cancer, Borderline tumors, Germ cell ovarian cancer, and Sex-cord stromal cell cancer. The cancer types are determined based on the location of the ovarian cells where the cancerous growth starts. After starting from ovaries, ovarian cancer spreads to the pelvis and abdomen region. Ovarian cancer is virtually undetectable when it is in the ovaries.
The strongest risk factors that can cause ovarian cancer are acquired genetic changes, genetic mutations called BRCA1 or BRCA2, old age, obesity, not having a full-term pregnancy, using fertility treatment, hormone therapy post menopause, and PTEN tumor hamartoma syndrome.
Download Free Report Brochure: https://www.zionmarketresearch.com/requestbro...cer-market
Factors such as increasing geriatric population of women rise in ovarian cancer cases, availability of new drugs and therapies, increase in healthcare expenditure, and increased government funding are expected to boost the growth of ovarian cancer market. However, availability of generic drugs and patent expiration of branded drugs can act as a restraint in the growth of the ovarian cancer market. The lack of precise diagnostic techniques for ovarian cancer in the early stages can also have a negative impact on the global ovarian cancer market.
On the basis of type, the ovarian cancer market has been divided into epithelial ovarian tumors, ovarian germ cell tumors, ovarian stromal tumors, and primary peritoneal carcinoma. On the basis of the cancer stage, the market is segmented into Stage I, Stage II, Stage III, and Stage IV. On the basis of diagnostics, the market divided into the physical examination, biopsy, blood tests, Human Chorionic Gonadotropin (hCG) test, ultrasound, MRI (Magnetic resonance imaging), PET (Positron emission tomography), and CT scans. On the basis of treatment, the market is divided into chemotherapy, targeted therapy, radiation therapy, immunotherapy, hormonal therapy, and surgery. In the forecast period, the diagnostic segment will dominate the global market as ovarian cancer is most chemosensitive cancer.
Browse the full "Ovarian Cancer Market by Type (Epithelial Ovarian Tumors, Ovarian Germ Cell Tumors, Ovarian Stromal Tumors, and Primary Peritoneal Carcinoma), by Cancer Stage (Stage I, Stage II, Stage III, and Stage IV), by Diagnostics (Physical Examination, Biopsy, Blood Tests, Human Chorionic Gonadotropin (hCG) test, ultrasound, MRI, PET, and CT scans), and by Treatment (Chemotherapy, Targeted Therapy, Radiation Therapy, Immunotherapy, Hormonal Therapy, and Surgery): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 - 2024" report at https://www.zionmarketresearch.com/report/ova...cer-market
North America was the largest regional market and expected to show significant growth in the years to come. In North America, the ovarian cancer market is growing due to the large patient pool and new product development.
In Asia Pacific, India and China are fastest developing markets as healthcare expenditure is rising in these regions, along with growing government funding and growing target patient pool.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/ov...cer-market
The Middle East & Africa is likely to register a stable growth rate. Latin America is another crucial regional market and is expected to experience reasonable growth over the forecast period. Thus, all the above-mentioned factors are expected to push the market growth in these regions.
Some of the key players in ovarian cancer market include Astra Zeneca Plc, Bristol Myers Squibb Company, Genentech Inc., Eli Lilly and Company, Novogen, Inc., GlaxoSmithKline Plc, Janssen Pharmaceuticals, Inc., Aetera Zenteris Inc., Boehringer Ingelheim GmbH, F. Hoffman-La Roche Ltd., and others.
Request customized copy of report @ https://www.zionmarketresearch.com/custom/3037
This report segments the global ovarian cancer market as follows:
Global Ovarian Cancer Market: by Type
- Epithelial Ovarian Tumors
- Ovarian Germ Cell Tumors
- Ovarian Stromal Tumors
- Primary Peritoneal Carcinoma
Global Ovarian Cancer Market: by Cancer Stage
- Stage I
- Stage II
- Stage III
- Stage IV
Global Ovarian Cancer Market: by Diagnostics
- Physical Examination
- Biopsy
- Blood Tests
Human Chorionic Gonadotropin (hCG) test
- Ultrasound
- MRI
- PET
- CT scans
Global Ovarian Cancer Market: by Treatment
- Chemotherapy
- Targeted Therapy
- Radiation Therapy
- Immunotherapy
- Hormonal Therapy
- Surgery
Global Ovarian Cancer Market: by Region
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East and Africa
Related Reports:
- Digital Pathology Market: https://www.zionmarketresearch.com/report/dig...ogy-market
- Compounding Pharmacies Market: https://www.zionmarketresearch.com/report/com...ies-market
- Hereditary Cancer Testing Market: https://www.zionmarketresearch.com/report/her...ing-market
- Epilepsy Therapeutics Market: https://www.zionmarketresearch.com/report/epi...ics-market
- Alzheimer’s Drugs Market: https://www.zionmarketresearch.com/report/alz...ugs-market
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research Follow Us Twitter: https://twitter.com/zion_research
Blog: http://www.intenseresearch.com | http://www.mrsresearchgroup.com | http://www.marketresearchtrade.com | https://qyresearchgroup.com | http://marketnreports.com | https://zmrnewsjournal.us | http://www.e-marketresearch.com
Contact Us:
Joel John 244 Fifth Avenue, Suite N202 New York, 10001, United States Tel: +49-322 210 92714 USA/Canada Toll-Free No.1-855-465-4651 Email: sales@zionmarketresearch.com
